AI Screening for Diabetic Retinopathy

• by Abraham Olvera-Barrios, MD, PhD, Cathy Egan, FRANZCO

• May 1, 2026

The Benefits of Intravitreal Steroids During Vitrectomy

Triamcinolone acetonide enhances vitreous visualization, facilitates surgical maneuvers, and provides postoperative anti-inflammatory effects.

• by John W. Kitchens, MD

• July 1, 2026

• 9 min

Ultra-Widefield Color Fundus Photography in Diabetic Retinopathy: From Panretinal Assessment to Multimodal Integration

• by Fang, Ruolin , Xu, Ruixuan , Wu, Zhipeng , Tong, Yuhua

• May 19, 2026

DME AWARE Study Defines Key Needs

Presenting results from the DME AWARE Delphi Study at the Association for Research in Vision and Ophthalmology (ARVO) meeting in Denver, Baruch D. Kuppermann, MD, PhD, director of the Gavin Herbert Eye Institute at the University of California, Irvine, described a set of consensus findings that point to unmet needs across the continuum of DME management, with particular emphasis on early intervention and noninvasive treatment options (Figure 1).

• by Jim Gallagher, senior managing editor

• May 1, 2026

• 5 min